Atlas Trials

Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment

Clinical trial NCT03389126 · COMPLETED

Trial details

NCT number
NCT03389126
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2017-12-01
Primary completion
2019-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.